Novo Nordisk Stock Could Benefit From Eli Lilly’s Weight-Loss Price Hikes

Published 2 months ago Negative
Novo Nordisk Stock Could Benefit From Eli Lilly’s Weight-Loss Price Hikes
Auto

Related Stocks

LILY34.SA Eli Lilly and C... LLY.BE Eli Lilly and C... LLY.MU Eli Lilly and C... LLY.MX Eli Lilly and C... N1VO34.SA Novo Nordisk A/... NOVO-B.CO Novo Nordisk A/...
The pricing of weight-loss drugs like Lilly’s Zepbound and Novo’s Wegovy is a pressure point for investors.

Continue Reading

View Comments

More News

Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research

33 minutes ago Positive

iHerb Kicks Off Global Gifting Season with its Annual Black Friday and Cyber Monday Sales Event

33 minutes ago Positive

Annexon Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

38 minutes ago Negative

James Hardie Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against James Hardie Industries plc - JHX

54 minutes ago Negative

Six Flags Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Six Flags Entertainment Corporation - FUN

58 minutes ago Negative